Literature DB >> 6896171

Effect of anti-thyroxin autoantibodies on radioimmunoassay of free thyroxin in serum.

J Konishi, Y Iida, T Kousaka, K Ikekubo, T Nakagawa, K Torizuka.   

Abstract

Serum thyroxin was nearly or completely undetectable by radioimmunoassay in an elderly patient with Graves' disease being treated with methimazole. Abnormal binding of thyroxin to antibodies of the IgG variety was shown, the association constant of the complex being 8.0 x 10(8) L/mol and the binding capacity 6.3 nmol/g of IgG. The effect of the antibody on results of radioimmunoassay of free thyroxin was studied with three commercial kits, two of which (Clinical Assays and Damon Diagnostics) gave essentially the same values as did equilibrium dialysis. The third (Amersham International) gave falsely high results because the 125I-labeled thyroxin derivative used in the kit was bound by the autoantibody.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896171

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Analytical and clinical evaluation of a new one-step non-analogue radioimmunoassay for serum-free thyroxine.

Authors:  R Sapin; F Gasser; J L Schlienger; J Chambron
Journal:  Eur J Nucl Med       Date:  1990

2.  Interference of anti-T3 autoantibodies in the measurement of total and free T3 in serum.

Authors:  R Abraham; R Chawla
Journal:  Indian J Clin Biochem       Date:  1997-12

3.  Interference of anti-T4 autoantibodies in the single step free T4 radioimmunoassays.

Authors:  R Abraham; R Chawla
Journal:  Indian J Clin Biochem       Date:  1998-07

Review 4.  Circulating thyroid hormone autoantibodies.

Authors:  S Benvenga; F Trimarchi; J Robbins
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

Review 5.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

6.  Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones.

Authors:  A Crinò; P Borrelli; R Salvatori; D Cortelazzi; R Roncoroni; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

7.  Antibody binding serum T3 in a patient with hepatocarcinoma.

Authors:  J Ordóñez-Llanos; J Rodríguez-Espinosa; J A Gómez-Gerique
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

8.  A new type of albumin with predominantly increased binding affinity for 3,3',5-triiodothyronine in a patient with Graves' disease.

Authors:  Y Yabu; K Miyai; A Kobayashi; K Miki; K Doi; J Takamatsu; T Mozai; F Matsuzuka; K Kuma
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

9.  Familial dysalbuminemic hyperthyroxinemia (FDH): inadequacy of the "analog" methods for assaying free-T4 levels.

Authors:  P De Nayer; P Malvaux; C Beckers
Journal:  Eur J Nucl Med       Date:  1984

10.  Clinical problems with a free thyroxine assay.

Authors:  P M Bell; T J Lyons; S J Todd; D R Hadden
Journal:  Ulster Med J       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.